Literature DB >> 22102243

The macromolecular complex of ICP and falcipain-2 from Plasmodium: preparation, crystallization and preliminary X-ray diffraction analysis.

Guido Hansen1, Britta Schwarzloh, Annika Rennenberg, Volker T Heussler, Rolf Hilgenfeld.   

Abstract

The malaria parasite Plasmodium depends on the tight control of cysteine-protease activity throughout its life cycle. Recently, the characterization of a new class of potent inhibitors of cysteine proteases (ICPs) secreted by Plasmodium has been reported. Here, the recombinant production, purification and crystallization of the inhibitory C-terminal domain of ICP from P. berghei in complex with the P. falciparum haemoglobinase falcipain-2 is described. The 1:1 complex was crystallized in space group P4(3), with unit-cell parameters a = b = 71.15, c = 120.09 Å. A complete diffraction data set was collected to a resolution of 2.6 Å.
© 2011 International Union of Crystallography. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102243      PMCID: PMC3212462          DOI: 10.1107/S1744309111034592

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  28 in total

1.  Likelihood-enhanced fast rotation functions.

Authors:  Laurent C Storoni; Airlie J McCoy; Randy J Read
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-02-25

2.  Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease.

Authors:  Stephanie X Wang; Kailash C Pandey; John R Somoza; Puran S Sijwali; Tanja Kortemme; Linda S Brinen; Robert J Fletterick; Philip J Rosenthal; James H McKerrow
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

3.  Solution structure and backbone dynamics of the Trypanosoma cruzi cysteine protease inhibitor chagasin.

Authors:  Didier Salmon; Rodolpho do Aido-Machado; Anne Diehl; Martina Leidert; Oliver Schmetzer; Ana P C de A Lima; Julio Scharfstein; Hartmut Oschkinat; José R Pires
Journal:  J Mol Biol       Date:  2006-02-03       Impact factor: 5.469

4.  Structural and functional characterization of Falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum.

Authors:  Tanis Hogg; Krishna Nagarajan; Saskia Herzberg; Lili Chen; Xu Shen; Hualiang Jiang; Maria Wecke; Christoph Blohmke; Rolf Hilgenfeld; Christian L Schmidt
Journal:  J Biol Chem       Date:  2006-06-15       Impact factor: 5.157

5.  Cadmium-induced crystallization of proteins: II. Crystallization of the Salmonella typhimurium histidine-binding protein in complex with L-histidine, L-arginine, or L-lysine.

Authors:  S Trakhanov; D I Kreimer; S Parkin; G F Ames; B Rupp
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

Review 6.  Cysteine proteases of malaria parasites.

Authors:  Philip J Rosenthal
Journal:  Int J Parasitol       Date:  2004-12       Impact factor: 3.981

7.  Influence of divalent cations in protein crystallization.

Authors:  S Trakhanov; F A Quiocho
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

8.  Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi.

Authors:  A C Monteiro; M Abrahamson; A P Lima; M A Vannier-Santos; J Scharfstein
Journal:  J Cell Sci       Date:  2001-11       Impact factor: 5.285

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

10.  The structure of Leishmania mexicana ICP provides evidence for convergent evolution of cysteine peptidase inhibitors.

Authors:  Brian O Smith; Nichola C Picken; Gareth D Westrop; Krystyna Bromek; Jeremy C Mottram; Graham H Coombs
Journal:  J Biol Chem       Date:  2005-12-28       Impact factor: 5.157

View more
  1 in total

Review 1.  Biological roles of cysteine proteinases in the pathogenesis of Trichomonas vaginalis.

Authors:  Hilda M Hernández; Ricardo Marcet; Jorge Sarracent
Journal:  Parasite       Date:  2014-10-28       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.